img

Global Immune Repertoire Sequencing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Immune Repertoire Sequencing Market Research Report 2024

Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
According to MRAResearch’s new survey, global Immune Repertoire Sequencing market is projected to reach US$ 128.8 million in 2033, increasing from US$ 103.3 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immune Repertoire Sequencing market research.
Key companies engaged in the Immune Repertoire Sequencing industry include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Immune Repertoire Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Immune Repertoire Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immune Repertoire Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific
Segment by Type
Pyro-Sequencing
Dye-Terminating Sequencing
Others

Segment by Application


Bioinformatics
Hematology
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immune Repertoire Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Pyro-Sequencing
1.2.3 Dye-Terminating Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immune Repertoire Sequencing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Bioinformatics
1.3.3 Hematology
1.3.4 Immunology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Repertoire Sequencing Market Perspective (2018-2033)
2.2 Immune Repertoire Sequencing Growth Trends by Region
2.2.1 Global Immune Repertoire Sequencing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immune Repertoire Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Immune Repertoire Sequencing Forecasted Market Size by Region (2024-2033)
2.3 Immune Repertoire Sequencing Market Dynamics
2.3.1 Immune Repertoire Sequencing Industry Trends
2.3.2 Immune Repertoire Sequencing Market Drivers
2.3.3 Immune Repertoire Sequencing Market Challenges
2.3.4 Immune Repertoire Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Repertoire Sequencing Players by Revenue
3.1.1 Global Top Immune Repertoire Sequencing Players by Revenue (2018-2023)
3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Repertoire Sequencing Revenue
3.4 Global Immune Repertoire Sequencing Market Concentration Ratio
3.4.1 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Repertoire Sequencing Revenue in 2022
3.5 Immune Repertoire Sequencing Key Players Head office and Area Served
3.6 Key Players Immune Repertoire Sequencing Product Solution and Service
3.7 Date of Enter into Immune Repertoire Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Repertoire Sequencing Breakdown Data by Type
4.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2024-2033)
5 Immune Repertoire Sequencing Breakdown Data by Application
5.1 Global Immune Repertoire Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immune Repertoire Sequencing Market Size (2018-2033)
6.2 North America Immune Repertoire Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Immune Repertoire Sequencing Market Size by Country (2018-2023)
6.4 North America Immune Repertoire Sequencing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune Repertoire Sequencing Market Size (2018-2033)
7.2 Europe Immune Repertoire Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Immune Repertoire Sequencing Market Size by Country (2018-2023)
7.4 Europe Immune Repertoire Sequencing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Repertoire Sequencing Market Size (2018-2033)
8.2 Asia-Pacific Immune Repertoire Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune Repertoire Sequencing Market Size (2018-2033)
9.2 Latin America Immune Repertoire Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Immune Repertoire Sequencing Market Size by Country (2018-2023)
9.4 Latin America Immune Repertoire Sequencing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Repertoire Sequencing Market Size (2018-2033)
10.2 Middle East & Africa Immune Repertoire Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptive Biotechnologies & Amgen
11.1.1 Adaptive Biotechnologies & Amgen Company Detail
11.1.2 Adaptive Biotechnologies & Amgen Business Overview
11.1.3 Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Introduction
11.1.4 Adaptive Biotechnologies & Amgen Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.1.5 Adaptive Biotechnologies & Amgen Recent Development
11.2 BGI
11.2.1 BGI Company Detail
11.2.2 BGI Business Overview
11.2.3 BGI Immune Repertoire Sequencing Introduction
11.2.4 BGI Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.2.5 BGI Recent Development
11.3 Alacris Theranostics
11.3.1 Alacris Theranostics Company Detail
11.3.2 Alacris Theranostics Business Overview
11.3.3 Alacris Theranostics Immune Repertoire Sequencing Introduction
11.3.4 Alacris Theranostics Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.3.5 Alacris Theranostics Recent Development
11.4 CD Genomics
11.4.1 CD Genomics Company Detail
11.4.2 CD Genomics Business Overview
11.4.3 CD Genomics Immune Repertoire Sequencing Introduction
11.4.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.4.5 CD Genomics Recent Development
11.5 AptaIT
11.5.1 AptaIT Company Detail
11.5.2 AptaIT Business Overview
11.5.3 AptaIT Immune Repertoire Sequencing Introduction
11.5.4 AptaIT Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.5.5 AptaIT Recent Development
11.6 ArcherDX
11.6.1 ArcherDX Company Detail
11.6.2 ArcherDX Business Overview
11.6.3 ArcherDX Immune Repertoire Sequencing Introduction
11.6.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.6.5 ArcherDX Recent Development
11.7 Roche Holding
11.7.1 Roche Holding Company Detail
11.7.2 Roche Holding Business Overview
11.7.3 Roche Holding Immune Repertoire Sequencing Introduction
11.7.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.7.5 Roche Holding Recent Development
11.8 ThermoFisher Scietific
11.8.1 ThermoFisher Scietific Company Detail
11.8.2 ThermoFisher Scietific Business Overview
11.8.3 ThermoFisher Scietific Immune Repertoire Sequencing Introduction
11.8.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2018-2023)
11.8.5 ThermoFisher Scietific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immune Repertoire Sequencing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Pyro-Sequencing
Table 3. Key Players of Dye-Terminating Sequencing
Table 4. Key Players of Others
Table 5. Global Immune Repertoire Sequencing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Immune Repertoire Sequencing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Immune Repertoire Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Immune Repertoire Sequencing Market Share by Region (2018-2023)
Table 9. Global Immune Repertoire Sequencing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Immune Repertoire Sequencing Market Share by Region (2024-2033)
Table 11. Immune Repertoire Sequencing Market Trends
Table 12. Immune Repertoire Sequencing Market Drivers
Table 13. Immune Repertoire Sequencing Market Challenges
Table 14. Immune Repertoire Sequencing Market Restraints
Table 15. Global Immune Repertoire Sequencing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Immune Repertoire Sequencing Market Share by Players (2018-2023)
Table 17. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Repertoire Sequencing as of 2022)
Table 18. Ranking of Global Top Immune Repertoire Sequencing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Immune Repertoire Sequencing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immune Repertoire Sequencing Product Solution and Service
Table 22. Date of Enter into Immune Repertoire Sequencing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immune Repertoire Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Immune Repertoire Sequencing Revenue Market Share by Type (2018-2023)
Table 26. Global Immune Repertoire Sequencing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Immune Repertoire Sequencing Revenue Market Share by Type (2024-2033)
Table 28. Global Immune Repertoire Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Immune Repertoire Sequencing Revenue Market Share by Application (2018-2023)
Table 30. Global Immune Repertoire Sequencing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Immune Repertoire Sequencing Revenue Market Share by Application (2024-2033)
Table 32. North America Immune Repertoire Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Immune Repertoire Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Immune Repertoire Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Immune Repertoire Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Immune Repertoire Sequencing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Immune Repertoire Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Immune Repertoire Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Immune Repertoire Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Adaptive Biotechnologies & Amgen Company Detail
Table 48. Adaptive Biotechnologies & Amgen Business Overview
Table 49. Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Product
Table 50. Adaptive Biotechnologies & Amgen Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 51. Adaptive Biotechnologies & Amgen Recent Development
Table 52. BGI Company Detail
Table 53. BGI Business Overview
Table 54. BGI Immune Repertoire Sequencing Product
Table 55. BGI Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 56. BGI Recent Development
Table 57. Alacris Theranostics Company Detail
Table 58. Alacris Theranostics Business Overview
Table 59. Alacris Theranostics Immune Repertoire Sequencing Product
Table 60. Alacris Theranostics Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 61. Alacris Theranostics Recent Development
Table 62. CD Genomics Company Detail
Table 63. CD Genomics Business Overview
Table 64. CD Genomics Immune Repertoire Sequencing Product
Table 65. CD Genomics Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 66. CD Genomics Recent Development
Table 67. AptaIT Company Detail
Table 68. AptaIT Business Overview
Table 69. AptaIT Immune Repertoire Sequencing Product
Table 70. AptaIT Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 71. AptaIT Recent Development
Table 72. ArcherDX Company Detail
Table 73. ArcherDX Business Overview
Table 74. ArcherDX Immune Repertoire Sequencing Product
Table 75. ArcherDX Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 76. ArcherDX Recent Development
Table 77. Roche Holding Company Detail
Table 78. Roche Holding Business Overview
Table 79. Roche Holding Immune Repertoire Sequencing Product
Table 80. Roche Holding Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 81. Roche Holding Recent Development
Table 82. ThermoFisher Scietific Company Detail
Table 83. ThermoFisher Scietific Business Overview
Table 84. ThermoFisher Scietific Immune Repertoire Sequencing Product
Table 85. ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2018-2023) & (US$ Million)
Table 86. ThermoFisher Scietific Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Repertoire Sequencing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immune Repertoire Sequencing Market Share by Type: 2022 VS 2033
Figure 3. Pyro-Sequencing Features
Figure 4. Dye-Terminating Sequencing Features
Figure 5. Others Features
Figure 6. Global Immune Repertoire Sequencing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Immune Repertoire Sequencing Market Share by Application: 2022 VS 2033
Figure 8. Bioinformatics Case Studies
Figure 9. Hematology Case Studies
Figure 10. Immunology Case Studies
Figure 11. Others Case Studies
Figure 12. Immune Repertoire Sequencing Report Years Considered
Figure 13. Global Immune Repertoire Sequencing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Immune Repertoire Sequencing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Immune Repertoire Sequencing Market Share by Region: 2022 VS 2033
Figure 16. Global Immune Repertoire Sequencing Market Share by Players in 2022
Figure 17. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Repertoire Sequencing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Immune Repertoire Sequencing Revenue in 2022
Figure 19. North America Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Immune Repertoire Sequencing Market Share by Country (2018-2033)
Figure 21. United States Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Immune Repertoire Sequencing Market Share by Country (2018-2033)
Figure 25. Germany Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Immune Repertoire Sequencing Market Share by Region (2018-2033)
Figure 33. China Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Immune Repertoire Sequencing Market Share by Country (2018-2033)
Figure 41. Mexico Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Immune Repertoire Sequencing Market Share by Country (2018-2033)
Figure 45. Turkey Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Immune Repertoire Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Adaptive Biotechnologies & Amgen Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 48. BGI Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 49. Alacris Theranostics Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 50. CD Genomics Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 51. AptaIT Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 52. ArcherDX Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 53. Roche Holding Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 54. ThermoFisher Scietific Revenue Growth Rate in Immune Repertoire Sequencing Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed